Document is current
Any future updates will be listed below
-
Authors
Sushentsev, Nikita https://orcid.org/0000-0003-4500-9714
Hamm, Gregory
Flint, Lucy
Birtles, Daniel https://orcid.org/0000-0002-5915-806X
Zakirov, Aleksandr
Richings, Jack
Ling, Stephanie https://orcid.org/0000-0002-1237-091X
Tan, Jennifer Y.
McLean, Mary A. https://orcid.org/0000-0002-3752-0179
Ayyappan, Vinay
Horvat Menih, Ines
Brodie, Cara
Miller, Jodi L. https://orcid.org/0000-0001-6870-204X
Mills, Ian G. https://orcid.org/0000-0001-5347-5083
Gnanapragasam, Vincent J.
Warren, Anne Y. https://orcid.org/0000-0002-1170-7867
Barry, Simon T. https://orcid.org/0000-0002-8511-0588
Goodwin, Richard J. A. https://orcid.org/0000-0001-5699-8488
Barrett, Tristan
Gallagher, Ferdia A.
-
Funding
Funding for this research was provided by:
Prostate Cancer UK (PA14-012)
- License Information
-
More Information
Article History
Received: 3 October 2023
Accepted: 7 July 2024
First Online: 16 July 2024
Competing interests
: G.H., L.F., D.B., J.R., S.L., J.Y.T., S.T.B., and R.J.A.G. are AstraZeneca employees. F.A.G. has research support from GE Healthcare and AstraZeneca, grants from GlaxoSmithKline, and has consulted for AstraZeneca on behalf of the University of Cambridge. The remaining authors declare no competing interests.
